Kyowa Hakko Kirin
TYO:4151 · JP3256000005
PharmaceuticalsX-Large
360
50
Medium confidence — indicative
Value75
Quality50
Growth42
Safety—
Sentiment32
Value Creation12/20creating some value
- Creates more value than its capital costs
- Owner earnings growing
- Owner earnings per share growing
- Reinvests at strong returns
- Solid earnings base
What this means
Kyowa Hakko Kirin clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.
Profile
CountryJapan
IndustryPharmaceuticals
SizeX-Large
TypePublic Company
ExchangeTSE
Founded1949
Employees486
Websitekyowakirin.co.jp/index.html
ISINJP3256000005
Last UpdateApr 2, 2026
Indices
Themes
CardiovascularImmunologyHematologyOphthalmologyNephrologyDermatologyOncologyCentral Nervous SystemBiotechnologyHealth CareManufacturingScience and Engineering
Description
Analysis
Bargain bin
Kyowa Kirin Co., Ltd. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.
360° rank · history
1007550250
61
2023202420252026
All-time high
83
Jan 2024
All-time low
23
Jan 2025
Average rank
60
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100